-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
Shi Si Yao Listed on the 2020 Hurun China Top 100 Private Health Enterprises.
Category:
Time：2020-03-23
Under the COVID-19 pandemic, the greater health industry has attracted considerable attention. On March 18, the Hurun Research Institute released for the first time the “2020 Hurun China Top 100 Private Greater Health Enterprises,” ranking 100 leading private greater health companies based on their market capitalization or valuation. Shisi Pharmaceutical Group ranked 83rd on the list with a market capitalization of 18 billion yuan.
Under the COVID-19 pandemic, the greater health industry has attracted considerable attention. On March 18, the Hurun Research Institute released for the first time the “2020 Hurun China Top 100 Private Greater Health Enterprises,” ranking 100 leading private greater health companies based on their market capitalization or valuation. Shisi Pharmaceutical Group ranked 83rd on the list with a market capitalization of 18 billion yuan.
Hu Run, Chairman and Chief Researcher of the Hurun Report, explained that in this ranking, “Chinese private enterprises” refer to non-state-owned enterprises headquartered on the Chinese mainland. For listed companies, market capitalization is calculated based on closing prices as of February 28, 2020; for unlisted companies, valuations are estimated by referencing those of comparable listed companies in the same industry. According to research data from the Hurun Research Institute, China’s greater healthcare sector has experienced rapid growth over the past decade. As China’s healthcare reform accelerates, the value of the greater healthcare sector has increased fivefold compared to five years ago and tenfold compared to ten years ago.
“This COVID-19 pandemic has drawn tremendous social attention to the greater health industry, as people are hoping these companies can help provide treatment solutions, protective supplies, or enhanced services. Now, these companies not only need to serve the domestic market but also face huge demand from overseas markets,” Hu Run pointed out.
Shisi Pharmaceutical Group is a high-tech enterprise that integrates the development of chemical drugs, traditional Chinese medicines, active pharmaceutical ingredients, pharmaceutical packaging materials, and the health industry. The group’s investment in industrial innovation has been steadily increasing year after year, and its market influence and competitiveness have been rapidly growing, earning widespread attention from the industry. Currently, Shisi Pharmaceutical Group’s flagship product—injectable formulations—cover the entire Chinese market and are now marketed in more than 80 countries and regions worldwide. During the COVID-19 pandemic, Shisi Pharmaceutical Group promptly provided emergency medicines and made generous donations to frontline epidemic prevention and control efforts, earnestly fulfilling its social responsibilities.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license